Turn this role into an interview — a resume and cover letter built around what this employer wants.
Convatec Infusion Care R&D team in the United Kingdom is seeking an Engineer to drive the design and development of new products, components and materials. You will manage change control and maintain regulatory-compliant documentation while collaborating across global teams.
You will develop test methods for verification and validation, conduct root-cause analyses, and contribute to IP generation while ensuring alignment with ISO 13485 and FDA 21 CFR 820 standards.
Infusion Care R&D Engineer responsible for Customer Projects, New Product Development, and Life Cycle Management of Infusion Care products.
Internal – R&D Engineers, Senior R&D Engineers, Senior Managers R&D, Project Managers, and other Core Team members (e.g. Advanced Operations, Artwork and Labelling, Regulatory, Design Assurance etc.) to execute projects and resolve product and process related issues.
External – Suppliers and Test Houses to obtain and provide relevant information to execute projects and resolve product and process related issues. Customers to provide status updates on ongoing projects.
Position may involve travel up to 10% of the time, mostly within Europe but overseas travel is expected. Most trips will include overnight travel.
Convatec is a multi-national company, therefore a degree of flexibility in the working day may be required when working with non-UK based colleagues.
Convatec provides equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectional or sexual orientation, gender identity, military or veteran status, genetic predisposing characteristics or any other basis prohibited by law.
Pioneering trusted medical solutions to improve the lives we touch:
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.